Qi Liu, Ph.D.

Clinical Pharmacology Team Leader, Oncology Drug Products, Division of Clinical Pharmacology 5, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Dr. Liu is a team leader in the Division of Clinical Pharmacology V of the Office of Clinical Pharmacology in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). Prior to joining the FDA, she worked as a senior pharmacokineticist at Merck & Co. She obtained her Ph.D. in pharmaceutics with a focus on pharmacokinetics/pharmacodynamics modeling and simulation from the University of Florida, concurrently earning a master’s degree in statistics. She also earned a master’s degree in pharmaceutics and a B.S in pharmacy from West China University of Medical Sciences.

In her current role at the FDA, Dr. Liu works in the area of oncology products with a focus on applying clinical pharmacology principles, including quantitative methods, to optimize the development of oncology drug products, such as dose selection and study design. She also has an interest in the application of machine learning, big data and real world evidence to advance precision medicine.